Medicon Hellas S.A. (ATH:MEDIC)
Greece flag Greece · Delayed Price · Currency is EUR
2.430
-0.020 (-0.82%)
At close: Mar 9, 2026

Medicon Hellas Company Description

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally.

It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories.

The company also produces and exports clinical chemistry, hematology and immunochemistry reagents. In addition, it offers analyzers, reagents, controls, calibrators, and consumables to biochemistry hematology, immunology, molecular, microbiology, and blood gases sectors; laboratory equipment, such as centrifugal, vortex/shakers, adjustable volume pipettes, and air purifiers; and cosmetics.

Further, the company provides service/refurbishment, diagnostic labs, and informatics/software services.

Medicon Hellas S.A. was incorporated in 1988 and is headquartered in Gerakas, Greece.

Medicon Hellas S.A.
Country Greece
Founded 1988
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 151
CEO Dimotsantos Spyridon

Contact Details

Address:
5-7 Melitona Street
Gerakas, 153 44
Greece
Phone 30 210 66 06 000
Website mediconsa.com

Stock Details

Ticker Symbol MEDIC
Exchange Athens Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
ISIN Number GRS424003002
SIC Code 3845

Key Executives

Name Position
Georgios Dimotsantos Deputy Chief Executive Officer and Executive Director
Dimotsantos S. Spyridon Chief Executive Officer and Chairman of the Board
George Kyridis Chief Financial Officer